LB Pharmaceuticals, Inc. (LBRX) Live Share Price, Invest From India

LB Pharmaceuticals, Inc. Stock Performance

as on August 20, 2026 at 6:59 am IST

Day's Low
Day's High
$48.23
Day's Price Range
$49.80
$48.92
1.41%
Downside
1.80%
Upside
52 Week's Low
52 Week's High
$13.36
52-Week Price Range
$49.14
$48.92
72.69%
Downside
0.45%
Upside

LB Pharmaceuticals, Inc. share price movements today

Previous Close: $48.77
Open: $49.80
Volume: 186.8K
Market Cap: $1.5B
Day's Low - High: $48.23 - $49.80
52 Week Low - High: $13.36 - $49.14

LB Pharmaceuticals, Inc. Historical Returns

1 Month Return: + 52.1 %
3 Month Return: + 61.08 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

LB Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check LB Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-5.556

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-50.00%

LB Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LB Pharmaceuticals, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
LB Pharmaceuticals, Inc.	StrongBuy	$1.5B	NA	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Analyst Recommendation on LB Pharmaceuticals, Inc. Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for LB Pharmaceuticals, Inc.. Average target price of $49.25

Indian Investors' Interest in LB Pharmaceuticals, Inc. Stock

Search interest for LB Pharmaceuticals, Inc. Stock has increased by 95% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 21, 2026 to August 20, 2026

Change:95% versus previous 30 day period

LB Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	0	-	-	-	0	0	0
Operating Income	-16	-26	-16	-5	-5	-5	-5	-13	-22
EBITDA	-16	-27	-14	-	-5	-5	-3	-11	-18
Interest Expense	-	-	-	-	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-27	-14	-5	-5	-5	-3	-11	-19
Income Tax Expense	-	-	-	-	-	-	-	0	-
Net Income	-16	-27	-14	-5	-5	-5	-3	-11	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

LB Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	0
Operating Income	-2	-11	-64	-30
EBITDA	-12	-1	-63	-24
Interest Expense	2	4	-	-
Depreciation	0	0	0	0
Income Before Tax	-14	-6	-63	-25
Income Tax Expense	0	0	0	0
Net Income	-14	-6	-63	-25
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

LB Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-27	-14	-5	-5	-4	-3	-11	-19	-51
Operating Cash Flow	-15	-22	-5	-8	-5	-3	-18	-23	-37
Investing Cash Flow	6	28	-	4	0	-44	0	0	0
Financing Cash Flow	0	0	-	-	-	303	-1	93	0
Change in Cash	-8	6	7	-3	-5	255	-19	70	-37

LB Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-63	-25
Operating Cash Flow	-12	-53	-35
Investing Cash Flow	-28	23	-39
Financing Cash Flow	33	38	302
Change in Cash	-6	8	227

Mutual Funds that own LB Pharmaceuticals, Inc. Stock

Check out the Mutual Funds with significant holdings in LB Pharmaceuticals, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.706898%	873223
JPMorgan Trust II	2.260801%	729316
BlackRock Funds	1.759583%	567627
JPMorgan Trust I	0.729869%	235450
Prudential Sector Funds, Inc.	0.71654%	231150

See all

Global Institutional Holdings in LB Pharmaceuticals, Inc.

Funds	Holdings
Peter Kolchinsky	6.85%
Vanguard	3.42%
iShares	3.07%
SPDR	0.7%
Felix Baker	0.62%

See all

Insights on LB Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, LBRX stock has moved up by 7.5%

About LB Pharmaceuticals, Inc.

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Organisation	LB Pharmaceuticals, Inc.
Headquarters	One Pennsylvania Plaza, New York, NY, United States, 10119
Industry	Biotechnology
CEO	Ms. Heather D. Turner Esq., J.D.
E-voting on shares	Click here to vote

Key Management of LB Pharmaceuticals, Inc.

Name	Title
Dr. James Rawls Pharm.D.	Senior Vice President of Regulatory Affairs
Ms. Ellen Rose	Senior Vice President of Corporate Affairs
Mr. Gad Soffer	Chief Operating & Business Officer
Ms. Lindsay Beaupre	Senior VP of People & Culture
Mr. Marc L. Panoff CPA	Senior Vice President of Finance
Ms. Minako Pazdera J.D., Ph.D.	General Counsel
Dr. Richard A. Silva Ph.D.	Senior Vice President of Technical Operations
Ms. Kaya Pai Panandiker Kamlesh	Chief Commercial Officer
Ms. Heather D. Turner Esq., J.D.	CEO & Director
Dr. Anna Eramo M.D.	Advisor

FAQs

What is LB Pharmaceuticals, Inc. share price today?

LB Pharmaceuticals, Inc. share price today is $48.92 as on August 20, 2026 at 1:29 am IST at the close of the market. LB Pharmaceuticals, Inc. share today touched a day high of $49.80 and a low of $48.23.

What is the 52 week high and 52 week low for LB Pharmaceuticals, Inc. share?

LB Pharmaceuticals, Inc. share touched a 52 week high of $49.14 on August 7, 2026 and a 52 week low of $13.36 on September 26, 2025. LB Pharmaceuticals, Inc. stock price today i.e. August 20, 2026 at 1:29 am IST is closed at $48.92,which is 0.45% down from its 52 week high and 266.17% up from its 52 week low.

What is LB Pharmaceuticals, Inc.'s market capitalisation today?

LB Pharmaceuticals, Inc. market capitalisation is $0.00T as on August 20, 2026 at 1:29 am IST.

How to invest in LB Pharmaceuticals, Inc. Stock (LBRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for LB Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in LB Pharmaceuticals, Inc. Shares that will get you 0.0307 shares as per LB Pharmaceuticals, Inc. share price of $48.92 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy LB Pharmaceuticals, Inc. Stock (LBRX) from India?

Indian investors can start investing in LB Pharmaceuticals, Inc. (LBRX) shares with as little as ₹95.743 or $1 (as of August 20, 2026 at 4:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in LB Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on August 20, 2026 at 4:36 am IST). Based on LB Pharmaceuticals, Inc. share’s latest price of $48.92 as on August 20, 2026 at 1:29 am IST, you will get 0.2044 shares of LB Pharmaceuticals, Inc.. Learn more about fractional shares .